Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 443139 in Participants With Early Manifest Huntington's Disease
Clinical trial NCT02519036 · COMPLETED
Trial details
- NCT number
- NCT02519036
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-06
- Primary completion
- 2017-11-08
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.